anmelden
NYSE International 100
11.210,79
PKT
-57,40
PKT
-0,51
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.01.25 | Deutsche Bank Outperform | RBC Capital Markets | |
| 31.01.25 | Deutsche Bank Kaufen | DZ BANK | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 31.01.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 31.01.25 | Nokia Neutral | UBS AG | |
| 31.01.25 | Philips Neutral | UBS AG | |
| 31.01.25 | BBVA Buy | Deutsche Bank AG | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Nokia Buy | Deutsche Bank AG | |
| 31.01.25 | Sanofi Hold | Deutsche Bank AG | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 31.01.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Mercedes-Benz Group (ex Daimler) Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Deutsche Bank Buy | Warburg Research | |
| 30.01.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Nokia Market-Perform | Bernstein Research | |
| 30.01.25 | Sanofi Outperform | Bernstein Research | |
| 30.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 30.01.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.01.25 | Nokia Neutral | UBS AG | |
| 30.01.25 | Sanofi Buy | UBS AG | |
| 30.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.01.25 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. |
